Corcept Therapeutics | Kostnadene For Salg



Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Alaunos Therapeutics 0 18K 2024-09
ANI Pharmaceuticals USD 80.28M 68.05M 2024-12
Ardelyx USD 18.26M 2.54M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Eli Lilly USD 2.4B 233M 2024-12
J&J USD 7.11B 151M 2024-12
Knight Therapeutics CAD 47.25M 990K 2024-09
Merck USD 3.71B 181M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Pfizer USD 5.65B 781M 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12



Corcept Therapeutics Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.